Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Primary care diabetes 2010-10, Vol.4 (3), p.129-137
Hauptverfasser: Ahmed, Mohamed H, Abu, Emmanuel O, Byrne, Christopher D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 3
container_start_page 129
container_title Primary care diabetes
container_volume 4
creator Ahmed, Mohamed H
Abu, Emmanuel O
Byrne, Christopher D
description Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.
doi_str_mv 10.1016/j.pcd.2010.02.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755404566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1751991810000306</els_id><sourcerecordid>755404566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEYpeFB-CCfAMOKXacxDErgapdCkhVOQBnyx1PNi5uHGxnUU-8Oi5dOHDAPtgjff9I801RPGV0wShrX-0WE5hFRXNNqwWl9b3inHWiK2nF6P38Fw0rpWTdWfEoxh2lLeOdeFicVbSSspL1efFz48dy6cAP3lkgK53SgaztLQZybSPqiOTFZrlaX798TTb4g8CgncPxBknvA7nBEYN2ZAoakk3W5zISPRpi95MPSY-JbOdgcPyND6hdGoie0-BDxjG-fVw86LWL-OTuvSi-rt59ufpQrj-9_3i1XJdQC55KUXfQYb6CCtZJbgStWsG2pmfQaQOc1xqkxLaRgLKXHFqOULdbCZ0UpuYXxfNT3yn47zPGpPY2AjqnR_RzVKJpalo3bZtJdiIh-BgD9moKdq_DQTGqjtrVTmXt6qhd0Upl7Tnz7K77vN2j-Zv44zkDlycA84y3FoOKYHEENDYgJGW8_W_7N_-kwdnRgnbf8IBx5-cwZnmKqZgD6vNx78e1M5oPpy3_BXnTqC4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755404566</pqid></control><display><type>article</type><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</creator><creatorcontrib>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</creatorcontrib><description>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</description><identifier>ISSN: 1751-9918</identifier><identifier>EISSN: 1878-0210</identifier><identifier>DOI: 10.1016/j.pcd.2010.02.004</identifier><identifier>PMID: 20299294</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cardiovascular diseases (CVDs) ; Cardiovascular Diseases - epidemiology ; Diabetes Mellitus, Type 2 - epidemiology ; Endocrinology &amp; Metabolism ; Fatty Liver - diagnosis ; Fatty Liver - epidemiology ; Fatty Liver - etiology ; Fatty Liver - therapy ; General Practice - organization &amp; administration ; Humans ; Internal Medicine ; Metabolic syndrome ; Non-alcoholic Fatty Liver Disease ; Non-alcoholic Fatty Liver Disease (NAFLD) ; Obesity - epidemiology ; Organizational Objectives ; Practice Guidelines as Topic ; Predictive Value of Tests ; Primary Health Care - organization &amp; administration ; Prognosis ; Regional Health Planning - organization &amp; administration ; Risk Factors</subject><ispartof>Primary care diabetes, 2010-10, Vol.4 (3), p.129-137</ispartof><rights>Primary Care Diabetes Europe</rights><rights>2010 Primary Care Diabetes Europe</rights><rights>Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</citedby><cites>FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pcd.2010.02.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20299294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmed, Mohamed H</creatorcontrib><creatorcontrib>Abu, Emmanuel O</creatorcontrib><creatorcontrib>Byrne, Christopher D</creatorcontrib><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><title>Primary care diabetes</title><addtitle>Prim Care Diabetes</addtitle><description>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</description><subject>Cardiovascular diseases (CVDs)</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Fatty Liver - diagnosis</subject><subject>Fatty Liver - epidemiology</subject><subject>Fatty Liver - etiology</subject><subject>Fatty Liver - therapy</subject><subject>General Practice - organization &amp; administration</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Metabolic syndrome</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Non-alcoholic Fatty Liver Disease (NAFLD)</subject><subject>Obesity - epidemiology</subject><subject>Organizational Objectives</subject><subject>Practice Guidelines as Topic</subject><subject>Predictive Value of Tests</subject><subject>Primary Health Care - organization &amp; administration</subject><subject>Prognosis</subject><subject>Regional Health Planning - organization &amp; administration</subject><subject>Risk Factors</subject><issn>1751-9918</issn><issn>1878-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcGO0zAQhiMEYpeFB-CCfAMOKXacxDErgapdCkhVOQBnyx1PNi5uHGxnUU-8Oi5dOHDAPtgjff9I801RPGV0wShrX-0WE5hFRXNNqwWl9b3inHWiK2nF6P38Fw0rpWTdWfEoxh2lLeOdeFicVbSSspL1efFz48dy6cAP3lkgK53SgaztLQZybSPqiOTFZrlaX798TTb4g8CgncPxBknvA7nBEYN2ZAoakk3W5zISPRpi95MPSY-JbOdgcPyND6hdGoie0-BDxjG-fVw86LWL-OTuvSi-rt59ufpQrj-9_3i1XJdQC55KUXfQYb6CCtZJbgStWsG2pmfQaQOc1xqkxLaRgLKXHFqOULdbCZ0UpuYXxfNT3yn47zPGpPY2AjqnR_RzVKJpalo3bZtJdiIh-BgD9moKdq_DQTGqjtrVTmXt6qhd0Upl7Tnz7K77vN2j-Zv44zkDlycA84y3FoOKYHEENDYgJGW8_W_7N_-kwdnRgnbf8IBx5-cwZnmKqZgD6vNx78e1M5oPpy3_BXnTqC4</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Ahmed, Mohamed H</creator><creator>Abu, Emmanuel O</creator><creator>Byrne, Christopher D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101001</creationdate><title>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</title><author>Ahmed, Mohamed H ; Abu, Emmanuel O ; Byrne, Christopher D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-748c8e8e87071893d702671bdf1c8adc334ac99e659ce9f93c63ec46b9c897d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Cardiovascular diseases (CVDs)</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Fatty Liver - diagnosis</topic><topic>Fatty Liver - epidemiology</topic><topic>Fatty Liver - etiology</topic><topic>Fatty Liver - therapy</topic><topic>General Practice - organization &amp; administration</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Metabolic syndrome</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Non-alcoholic Fatty Liver Disease (NAFLD)</topic><topic>Obesity - epidemiology</topic><topic>Organizational Objectives</topic><topic>Practice Guidelines as Topic</topic><topic>Predictive Value of Tests</topic><topic>Primary Health Care - organization &amp; administration</topic><topic>Prognosis</topic><topic>Regional Health Planning - organization &amp; administration</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmed, Mohamed H</creatorcontrib><creatorcontrib>Abu, Emmanuel O</creatorcontrib><creatorcontrib>Byrne, Christopher D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Primary care diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmed, Mohamed H</au><au>Abu, Emmanuel O</au><au>Byrne, Christopher D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?</atitle><jtitle>Primary care diabetes</jtitle><addtitle>Prim Care Diabetes</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>4</volume><issue>3</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>1751-9918</issn><eissn>1878-0210</eissn><abstract>Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic dysfunction encountered in general practice. A large proportion of individuals with type 2 diabetes and the metabolic syndrome develop NAFLD. NAFLD is associated with severe insulin resistance and increased risk of cardiovascular disease and can progress to non-alcoholic steato-hepatitis, liver cirrhosis and cancer. Currently the only known effective treatments for NAFLD are lifestyle changes including stable weight loss and a diet low in calories. General practitioners will increasingly play a key role in dealing with this evolving but serious epidemic of NAFLD and associated metabolic complications. However, success will depend on the appropriate systems and mechanisms being in place in primary care and the proper motivation, support and education of the patient. This review provides the primary care physician with: (a) a step-by step guide of how to identify NAFLD, (b) information to exclude common other causes of liver fat accumulation and (c) additional insight into relationships between NAFLD and other conditions such as obesity, cardiovascular disease and type 2 diabetes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20299294</pmid><doi>10.1016/j.pcd.2010.02.004</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1751-9918
ispartof Primary care diabetes, 2010-10, Vol.4 (3), p.129-137
issn 1751-9918
1878-0210
language eng
recordid cdi_proquest_miscellaneous_755404566
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cardiovascular diseases (CVDs)
Cardiovascular Diseases - epidemiology
Diabetes Mellitus, Type 2 - epidemiology
Endocrinology & Metabolism
Fatty Liver - diagnosis
Fatty Liver - epidemiology
Fatty Liver - etiology
Fatty Liver - therapy
General Practice - organization & administration
Humans
Internal Medicine
Metabolic syndrome
Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease (NAFLD)
Obesity - epidemiology
Organizational Objectives
Practice Guidelines as Topic
Predictive Value of Tests
Primary Health Care - organization & administration
Prognosis
Regional Health Planning - organization & administration
Risk Factors
title Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A29%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-Alcoholic%20Fatty%20Liver%20Disease%20(NAFLD):%20New%20challenge%20for%20general%20practitioners%20and%20important%20burden%20for%20health%20authorities?&rft.jtitle=Primary%20care%20diabetes&rft.au=Ahmed,%20Mohamed%20H&rft.date=2010-10-01&rft.volume=4&rft.issue=3&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=1751-9918&rft.eissn=1878-0210&rft_id=info:doi/10.1016/j.pcd.2010.02.004&rft_dat=%3Cproquest_cross%3E755404566%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755404566&rft_id=info:pmid/20299294&rft_els_id=1_s2_0_S1751991810000306&rfr_iscdi=true